<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40"><head><meta name=Title content=""><meta name=Keywords content=""><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Arial;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal;
font-family:"Arial",sans-serif;
color:#003192;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.msoIns
{mso-style-type:export-only;
mso-style-name:"";
text-decoration:underline;
color:teal;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.WordSection1
{page:WordSection1;}
--></style></head><body bgcolor=white lang=EN-US link="#0563C1" vlink="#954F72"><div class=WordSection1><p class=MsoNormal><span style='font-size:10.0pt'>Dear WG Members,<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'>Attached, please see a letter sent to Work Track 3 and shared with the group on 19 Dec 2017.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'>Please note, we’ve established a New gTLD Subsequent Procedures Correspondence page where this and future correspondence to this PDP WG can be made available: <a href="https://community.icann.org/x/3B5yB">https://community.icann.org/x/3B5yB</a><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'>Best,<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'>Steve<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><o:p> </o:p></span></p><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b><span style='font-size:12.0pt;color:black'>From: </span></b><span style='font-size:12.0pt;color:black'>Gnso-newgtld-wg-wt3 <gnso-newgtld-wg-wt3-bounces@icann.org> on behalf of Karen Day <Karen.Day@sas.com><br><b>Date: </b>Tuesday, December 19, 2017 at 10:26 AM<br><b>To: </b>"gnso-newgtld-wg-wt3@icann.org" <gnso-newgtld-wg-wt3@icann.org><br><b>Subject: </b>[Gnso-newgtld-wg-wt3] FW: Letter on behalf of FIP<o:p></o:p></span></p></div><div><p class=MsoNormal><o:p> </o:p></p></div><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'>Dear Work Track 3 Members,</span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'> </span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'>Please see the attached letter which we have received this morning for your consideration into our work.</span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'> </span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'>Best regards,</span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'>Karen</span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'> </span><o:p></o:p></p><p class=MsoNormal><span style='font-family:"Arial",sans-serif;color:#003192'> </span><o:p></o:p></p><div><div style='border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b>From:</b> Rachel van Kesteren [mailto:Rachel@fip.org] <br><b>Sent:</b> Tuesday, December 19, 2017 7:03 AM<br><b>To:</b> Karen Day <Karen.Day@sas.com>; robin@ipjustice.org<br><b>Cc:</b> CEO@fip <ceo@fip.org>; President <president@fip.org>; Carola van der Hoeff <Carola@fip.org>; Thomas Menighan <tmenighan@aphanet.org><br><b>Subject:</b> Letter on behalf of FIP<o:p></o:p></p></div></div><p class=MsoNormal> <o:p></o:p></p><p><b><i><span lang=EN-GB style='font-size:12.0pt;font-family:"Arial",sans-serif;color:red'>EXTERNAL</span></i></b><span lang=EN-GB style='font-size:12.0pt;font-family:"Arial",sans-serif;color:red'> </span><o:p></o:p></p><div><p class=MsoNormal><span lang=EN-GB>Dear Ms Day and Ms Gross,</span><o:p></o:p></p><p class=MsoNormal><span lang=EN-GB>Please find attached a letter on behalf of Ms Ema Paulino, Interim CEO.</span><o:p></o:p></p><p class=MsoNormal><span lang=EN-GB>Kind regards,</span><o:p></o:p></p><p class=MsoNormal><span lang=EN-GB>Rachel </span><o:p></o:p></p><p class=MsoNormal><span lang=EN-GB> </span><o:p></o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=611 style='width:458.25pt'><tr style='height:101.25pt'><td width=21 style='width:15.75pt;padding:0in 0in 0in 0in;height:101.25pt'><p class=MsoNormal style='mso-margin-top-alt:auto;margin-bottom:12.0pt'><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.fip.org_&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=e23YSM41yAMRc-kDortTPZgatVaA1T6FCSecsPG_N-s&e=" target="''"><span style='font-size:12.0pt;font-family:"Times New Roman",serif;color:blue;mso-fareast-language:EN-GB;text-decoration:none'><img border=0 width=130 height=75 id="_x0000_i1025" src="cid:image001.png@01D379AF.EECA9D50"></span>[fip.org]</a><o:p></o:p></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0><tr><td valign=top style='padding:0in 3.75pt 0in 0in'><p class=MsoNormal align=center style='text-align:center'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.facebook.com_InternationalPharmaceuticalFederation_&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=rVI0-_bUPggRJV4I1L8dYWrbJbEAZWhBayA9W54z-4E&e=" target="''"><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:blue;mso-fareast-language:EN-GB;text-decoration:none'><img border=0 width=30 height=30 id="_x0000_i1026" src="cid:image002.png@01D379AF.EECA9D50"></span>[facebook.com]</a><o:p></o:p></p></td><td valign=top style='padding:0in 3.75pt 0in 0in'><p class=MsoNormal align=center style='text-align:center'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.linkedin.com_company_fip&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=_iMI6NSR6mj-6PlaayQAJMcLf0U7CvMa4f4fkLrzTMo&e=" target="''"><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:blue;mso-fareast-language:EN-GB;text-decoration:none'><img border=0 width=30 height=30 id="_x0000_i1027" src="cid:image003.png@01D379AF.EECA9D50"></span>[linkedin.com]</a><o:p></o:p></p></td><td valign=top style='padding:0in 3.75pt 0in 0in'><p class=MsoNormal align=center style='text-align:center'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__twitter.com_FIPCongress&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=L6j4Iuq5ChuZPnwlefi5mzaL0InkunwEdAj5HT5YBrw&e=" target="''"><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:blue;mso-fareast-language:EN-GB;text-decoration:none'><img border=0 width=30 height=30 id="_x0000_i1028" src="cid:image004.png@01D379AF.EECA9D50"></span>[twitter.com]</a><o:p></o:p></p></td><td valign=top style='padding:0in 3.75pt 0in 0in'><p class=MsoNormal align=center style='text-align:center'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.youtube.com_user_IAmAPharmacistVideos&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=CfR2yb8QILXTMexTi7wojy1UOuNbf2pFsgh1De-x0mg&e=" target="''"><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:blue;mso-fareast-language:EN-GB;text-decoration:none'><img border=0 width=30 height=30 id="_x0000_i1029" src="cid:image005.png@01D379AF.EECA9D50"></span>[youtube.com]</a><o:p></o:p></p></td></tr></table></td><td style='padding:0in 0in 0in 0in;height:101.25pt'><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br><br><br></span><b><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>Rachel</span></b><span style='font-size:10.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> <b><span style='color:#1DC1E8'>van Kesteren</span></b> | <i><span style='color:black'>Executive Secretary</span></i></span><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span><b><span style='font-size:10.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>International Pharmaceutical Federation (FIP)</span></b><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>Andries Bickerweg 5</span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> | </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>2517 JP</span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> | </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>The Hague</span><span style='font-size:10.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> | </span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>The </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>Netherlands</span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> <br></span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:black;mso-fareast-language:EN-GB'>Tel: </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>+31 70 302 1971</span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:black;mso-fareast-language:EN-GB'>| Fax: </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>+31 70 302 1999</span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'> <br></span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:black;mso-fareast-language:EN-GB'>Email:</span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="mailto:Rachel@fip.org" title="Click to send email to Rachel van Kesteren"><span style='color:#1DC1E8'>Rachel@fip.org</span></a></span><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.fip.org&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=Wt9vu2cnQwu8GtAW9iP6dmvpNa3-rJZnbOHr1XAb8v0&e="><span style='color:#1DC1E8'>Website</span>[fip.org]</a></span><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:black;mso-fareast-language:EN-GB'> | </span></b><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.fip.org_events&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=ds8ZCvI2H97uBY5n9EG8_guRHBnwUcw_iqSFtc0RqGc&e="><span style='color:#1DC1E8'>Pharmacy Event Calendar</span>[fip.org]</a></span><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:black;mso-fareast-language:EN-GB'> | </span></b><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.fip.org_publications&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=fRCtxWZcPcm5So1fNm9II6NsWr9xDrouvU7_P97U9qE&e="><span style='color:#1DC1E8'>Publications</span>[fip.org]</a></span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> </span><o:p></o:p></p></td></tr><tr><td style='padding:0in 0in 0in 0in'><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-language:EN-GB'><img border=0 width=110 height=80 id="_x0000_i1030" src="cid:image006.png@01D379AF.EECA9D50"></span><o:p></o:p></p></td><td style='padding:0in 0in 0in 0in'><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><b><u><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span></u></b><u><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.fip.org_glasgow2018_&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=u0XAbNKSWH9GIvRhNNxBikE1MmNg1nf8is4sQg0svxw&e="><span style='color:#1DC1E8'>Website</span>[fip.org]</a></span></u><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> | </span></b><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.fip.org_glasgow2018_programme_&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=K3gaUjorAwUOJH-pCjgaNUGzscN8hERVtfMk-0iRUz4&e="><span style='color:#1DC1E8'>Programme</span>[fip.org]</a></span><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> |</span></b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> </span><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.fip.org_glasgow2018_press-2Dand-2Dmedia_&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=DiWpLcU3nq12bdPzIiY60rJXCESmBl3QAQQGBS0j5JM&e="><span style='color:#1DC1E8'>Press & Media</span>[fip.org]</a></span><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> | </span></b><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.fip.org_glasgow2018_housing_&d=DwMFAg&c=FmY1u3PJp6wrcrwll3mSVzgfkbPSS6sJms7xcl4I5cM&r=UAy6fqdE7uFkRCc7uzN4yui8bwTtqofadZHiQEIO1vw&m=ZcJExkmEgeGZLiyu9F6ltZxsDGfgF_2IWEC4itZJyIg&s=jLnoCSz7zBnGKQXY6HDnwvd69Xkmm1Wo2YFuJQIdOLk&e="><span style='color:#1DC1E8'>Glasgow</span>[fip.org]</a></span><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span><i><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>Join us on 2 September - 6 September 2018, Glasgow</span></i><o:p></o:p></p></td></tr><tr><td style='padding:0in 0in 0in 0in'><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-language:EN-GB'><img border=0 width=110 height=42 id="_x0000_i1031" src="cid:image007.png@01D379AF.EECA9D50"></span><o:p></o:p></p></td><td style='padding:0in 0in 0in 0in'><p class=MsoNormal><u><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span></u><u><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>Website</span></u><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> | </span></b><u><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>Programme</span></u><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> | </span></b><u><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>Press & Media</span></u><b><span style='font-size:7.5pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'> | </span></b><u><span style='font-size:8.0pt;font-family:"Arial",sans-serif;color:#1DC1E8;mso-fareast-language:EN-GB'>Geneva</span></u><span style='font-size:12.0pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'><br></span><span style='font-size:7.5pt;font-family:"Arial",sans-serif;mso-fareast-language:EN-GB'>Join us on 19 May - 20 May 2018, Geneva<br>World Health Professions Regulation Conference 2018</span><o:p></o:p></p></td></tr></table><p class=MsoNormal><i><span style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#8B8B8B'><br>The International Pharmaceutical Federation (FIP) is the global federation of 140 national organisations <br>of pharmacists and pharmaceutical scientists dedicated to improving the access to and value of <br>appropriate medicine use, and contributing to changes in science, practice and health policies worldwide.<br>FIP represents over four million pharmacists and pharmaceutical scientists worldwide and endeavors <br>to advance the role of the pharmacist through such partnerships as our official NGO status with the <br>World Health Organization (WHO).</span></i><span style='font-size:7.5pt;font-family:"Times New Roman",serif;color:#8B8B8B;mso-fareast-language:EN-GB'> </span><o:p></o:p></p></div></div></body></html>